The MELD-Na calculator is an evolution of the Model for End-Stage Liver Disease (MELD) scoring system. The original MELD score was developed to predict mortality within three months of surgery in patients who had undergone a transjugular intrahepatic portosystemic shunt (TIPS) procedure. It was found to be an effective tool for determining the prognosis and prioritizing patients for liver transplant.
Recognizing its accuracy in predicting short-term survival among patients with cirrhosis, the United Network for Organ Sharing (UNOS) adopted MELD in 2002 for prioritizing patients awaiting liver transplantation in the United States. MELD is a prognostic score that measures the severity of liver failure to estimate short-term survival in patients with chronic liver disease.
The original MELD calculator used measurements of creatinine, bilirubin, and INR. It was later discovered that hyponatremia (low sodium concentration in the blood) was an independent predictor of mortality in patients with cirrhosis. Consequently, sodium levels were integrated into the MELD score to improve its predictive accuracy, leading to the creation of the MELD-Na score. This new scoring system, MELDNa, includes the serum sodium parameter to account for the added risk of significant hyponatremia. The MELD-Na calculator thus became a more comprehensive tool for assessing the severity of liver disease and the urgency of liver transplantation.
The MELD-Na calculator is designed to:
MELD scores, which the calculator determines, range from 6 to 40. A higher MELD score signifies a greater risk of 3-month mortality due to liver disease.
The MELD-Na calculation uses the following laboratory values:
Creatinine
(mg/dL)Bilirubin
(mg/dL)INR
(International Normalized Ratio)Serum Sodium
(mmol/L)